PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wheaton Precious Metals Corp. (WPM)
96.701.20 (1.26%)
95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.46%
Revenue growth similar to FSM's 17.72%. Walter Schloss would see if both companies share industry tailwinds.
15.06%
Gross profit growth under 50% of FSM's 41.20%. Michael Burry would be concerned about a severe competitive disadvantage.
16.70%
EBIT growth below 50% of FSM's 205.32%. Michael Burry would suspect deeper competitive or cost structure issues.
16.70%
Operating income growth under 50% of FSM's 205.32%. Michael Burry would be concerned about deeper cost or sales issues.
-306.84%
Negative net income growth while FSM stands at 232.49%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-306.67%
Negative EPS growth while FSM is at 250.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-306.67%
Negative diluted EPS growth while FSM is at 250.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.14%
Share change of 0.14% while FSM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.16%
Slight or no buyback while FSM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-9.68%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
27.85%
OCF growth at 50-75% of FSM's 42.04%. Martin Whitman would question if the firm lags in monetizing sales effectively.
27.22%
FCF growth under 50% of FSM's 90.06%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
143.50%
10Y revenue/share CAGR under 50% of FSM's 321.53%. Michael Burry would suspect a lasting competitive disadvantage.
-32.40%
Negative 5Y CAGR while FSM stands at 55.29%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
44.73%
3Y revenue/share CAGR at 75-90% of FSM's 58.95%. Bill Ackman would expect new product strategies to close the gap.
141.95%
10Y OCF/share CAGR 1.25-1.5x FSM's 120.33%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
-47.98%
Negative 5Y OCF/share CAGR while FSM is at 28.89%. Joel Greenblatt would question the firm’s operational model or cost structure.
46.92%
3Y OCF/share CAGR under 50% of FSM's 148.53%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-379.09%
Negative 10Y net income/share CAGR while FSM is at 989.58%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-162.02%
Negative 5Y net income/share CAGR while FSM is 214.71%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-321.70%
Negative 3Y CAGR while FSM is 47684.83%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
215.88%
10Y equity/share CAGR 1.25-1.5x FSM's 149.24%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
26.24%
Below 50% of FSM's 66.41%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
13.10%
Below 50% of FSM's 64.87%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
7.02%
Dividend/share CAGR of 7.02% while FSM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
62.84%
3Y dividend/share CAGR of 62.84% while FSM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-45.82%
Firm’s AR is declining while FSM shows 9.64%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-4.25%
Negative asset growth while FSM invests at 8.23%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.45%
We have a declining book value while FSM shows 6.54%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-9.84%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-1.81%
We cut SG&A while FSM invests at 71.83%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.